Valvular disease refers to conditions affecting the heart valves, crucial components responsible for maintaining the unidirectional flow of blood within the heart. The heart has four valves—mitral, aortic, tricuspid, and pulmonary—that open and close synchronously to facilitate efficient blood circulation. Valvular diseases can manifest as stenosis (narrowing) or regurgitation (leakage), both of which compromise the heart's ability to pump blood effectively. Causes may include congenital defects, infections, or age-related degeneration. Symptoms range from chest pain and fatigue to shortness of breath. Timely diagnosis through imaging studies and echocardiograms is crucial for appropriate management, which may involve medications, lifestyle changes, or, in severe cases, surgical intervention to repair or replace the affected valve. Effective management of valvular diseases is paramount for maintaining heart health and preventing complications.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India